Understanding New Genetic and Biomarker Variants in Young Adults with Acute Myocardial Infarction
Study of Heart Attack Causes in Adults Aged 21 to 60 with Few Cardiovascular Risk Factors
Led by National Heart Centre Singapore · Updated on 2024-11-21
1200
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Cardiovascular disease CVD causes significant illness and death worldwide, yet many unknowns remain about its development. This study focuses on young adults who have experienced acute myocardial infarction AMI, particularly those under 50 with few traditional cardiovascular risk factors, and those aged 51-60 with no more than two risk factors excluding diabetes. Researchers aim to identify new gene variants and biomarkers linked to early heart attacks in Chinese, Malay, and Indian patients to better understand and potentially prevent CVD in these groups.
Participants in this observational study will be grouped by age and cardiovascular risk factor status. Group 1 includes patients 50 years old or younger regardless of risk factors, while Group 2 includes patients aged 51-60 with no more than two risk factors excluding diabetes. The main procedure involves blood draws to collect samples for genomic, proteomic, and metabolomic analyses to discover novel genes and proteins associated with myocardial infarction.
During the study, participants will provide informed consent and comply with study visits and procedures, including blood collection. Researchers will analyze the samples to identify new gene variants and other biomarkers linked to early heart attacks over a five-year period. The primary outcome is to find gene variants associated with MI onset, while secondary outcomes include identifying proteins, lipids, and metabolites related to MI. This research aims to improve understanding of young adult heart attacks and help tailor future prevention and treatment.
CONDITIONS
Brief Title
UNdeRstAnding Novel Variants in AcutE MyocardiaL Infarction in Young Adults
Research Team
T
Tze Theng Goh
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Age 50 years or younger regardless of cardiovascular risk factors at time of myocardial infarction
Age 51 to 60 years old with no more than two cardiovascular risk factors excluding diabetes at time of myocardial infarction
Able to provide informed consent
Willing and able to comply with study visits and procedures
Prior type 1 myocardial infarction with angiographic or CT evidence of significant artery narrowing (≥50% in left main or ≥70% in major vessels)
Self-identified as Chinese, Malay, or Indian
You will not qualify if you...
Known familial hypercholesterolaemia, vasculitis, end-stage kidney disease, or congenital heart disease
Prior peripheral artery disease or stroke
Pregnant females
Non-Asian patients
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Sample Collection
Duration - At enrollment and ongoing assessments as scheduled
Participants provide blood samples for analysis of gene variants and biomarkers associated with myocardial infarction.
1 visit at enrollment; additional visits may occur depending on study assessments
Long-term Monitoring
Duration - Up to 5 years
Participants are followed for up to 5 years to identify novel gene variants and biomarkers related to myocardial infarction.
Periodic visits for assessments during follow-up
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Long-Term Study of Acute Myocardial Infarction Patients Treated with Medication, Surgery, or Intervention at Asan Medical Center
Long-term Study of Atorvastatin and Ezetimibe Treatment Effects on Heart Function, Artery Health, and Quality of Life in Adults Aged 30 to 70 With Recent Heart Attack
Study of Intravenous Ferric Carboxymaltose to Reduce Death, Heart Failure Events, and Improve Quality of Life in Adults with Iron Deficiency After Recent Heart Attack
Study of High-Sensitivity Troponin I Testing Alongside Standard Emergency Care in Ambulance Services for Adults With Chest Pain or Suspected Heart Attack
Study Comparing Gum Health in Adults Aged 20 to 90
With and Without Recent Heart Attack
Tomsk City Registry for Collecting and Analyzing Heart Attack Data to Monitor Acute Myocardial Infarction
Testing Eplerenone Treatment in Adults With Heart Attack or Injury Without Blocked Coronary Arteries Using Stratified Medicine
Optimal Timing of FFR-Guided Complete Revascularization in Patients With Non-ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Understanding New Genetic and Biomarker Variants in Young Adults with Acute Myocardial Infarction
Study of Heart Attack Causes in Adults Aged 21 to 60 with Few Cardiovascular Risk Factors
Follow-up Study of Young Women Who Had an Acute Myocardial Infarction in France to Understand Long-Term Health and Quality of Life
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study.
Svati H Shah, Christopher B Granger, Elizabeth R Hauser...